Cancer Statewide Clinical Network
Current projects
South Australian Cancer Plan
The Cancer Statewide Clinical Network is providing strategic expertise relating to the content of the South Australian Cancer Plan. For more information, please visit the SA Cancer Plan webpage on the SA Health website.
Germline Testing
Development of a statewide germline testing framework for cancer care. To view the mainstream genetic testing packs please visit the AGU Website on the SA Health website.
Cancer Navigation
Cancer navigation refers to how a patient navigates cancer care and is a key element of coordinated, person-centred care and support. Cancer navigation works to improve access to care and continuity of care, particularly among populations experiencing unmet needs and disparities in cancer care.
The Cancer Statewide Clinical Network (SCN) rated efficient and equitable cancer navigation as the highest priority to improve and address in 2023. This was identified through a comprehensive workshopping process undertaken with the SCCN to identify and prioritise network projects.
We’re excited to partner with the Caring Futures Institute (CFI) on the ‘Cancer Navigation Project’, to develop South Australian cancer navigation framework, which imagines a future where the highest standard of healthcare is available to all and where people are truly at the centre.
The Cancer Navigation Project will soon commence consumer and stakeholder (including cancer care professionals, government, and non-government organisations) engagement to co-design the framework and implementation plan and consider application to the South Australian Cancer Plan currently under development.
The SA Cancer Plan is envisaged to set the future direction of cancer care across SA and helps to identify opportunities to create a coordinated, integrated, equitable, evidence-based, personalised care system across the cancer continuum. Key intended clinical benefits include:
- Improved timely access to and provision of safe and accessible services that are inclusive of multidisciplinary teams, as close to home as possible for patients.
- Improved health status of the South Australian population whilst developing a health system that facilitates equity of access.
- Creation of a responsive health system that meets the needs of the community.
Chimeric Antigen Receptor T-cell (CAR T-cell) Therapy
The Cancer Statewide Clinical Network have led collaborations with a multidisciplinary group of clinicians and researchers across all local health networks to outline what is needed to facilitate the delivery of CAR T‑cells in South Australia. A project has been initiated to investigate and formulate strategies to establish a CAR T‑cell therapy service in South Australia.
Chimeric Antigen Receptor T‑cell (CAR T‑cell) Therapy is an evidence-based, internationally recognised therapy endorsed by Cancer Australia and the Australian Government Medical Specialist Advisory Committee (MSAC) which can improve chance of cure for certain types of leukaemia and lymphoma. The establishment of a South Australian service would allow patients to access this care closer to home thereby improving their quality of life. It would also enhance equity of access for those who may be unable to travel interstate to receive this treatment.
What is CAR T‑cell therapy? An introduction to CAR T‑cell therapy video has been published by NSW Health Immune Effector Cell Service which was in partnership with the NSW Agency for Clinical Innovation.
For more information, visit the Agency for Clinical Information website.
Developing a standardised platform to assist with multidisciplinary team (MDT) meetings.
Cancer care in Australia is best provided by a multidisciplinary team of professionals. Regular multidisciplinary team (MDT) meetings are an integral component of providing comprehensive care to people with cancer. During these meetings, clinicians review the radiology and pathology results and discuss the most appropriate treatment plan for an individual patient.
In South Australia, there are more than 30 MDT meetings occurring every month integrated across the public and private sector, however currently, there is no state-wide standardised approach to documenting MDTs’ and capturing MDT data. We are working toward implementing a platform that connects vital patient information and results in order to better support the important decision making and planning.
The Cancer Statewide Clinical Network has contributed to outlining MDT specification requirements, based on the outcomes of a stakeholder engagement workshop which involved clinical experts and consumers.
Upcoming projects
- Implementation of the SA Cancer Plan — The Cancer SCN will play a central role in implementing the key components of the SA Cancer Plan. This is due to commence late 2023.
Hear from Dr Ganessan Kichenadasse about the Cancer Statewide Clinical Network as part of the 2022 CEIH Conversation Series
Cancer Statewide Clinical Network Steering Committee
Dr Michael Osborn |
Haematologist/Paediatric, Adolescent and Young Adult Oncologist and Clinical Lead Cancer Statewide Clinical Network; WCHN/ RAH |
Mrs Amanda Robertson |
Information and Support Manager; Cancer Council SA |
Dr Anas Alawawdeh |
Consultant Medical Oncologist; Rural Support Service |
A/Prof Anna Brown |
Head of Molecular Oncology, Co-group leader, Familial Haematological Cancer Group; SA Pathology/University of South Australia |
Mr Arrin Wislang |
Manager, Clinical Services; Rural Support Service |
Ms Belinda Morris |
Lead Pharmacy Analyst – eCPS; Digital Health SA |
Dr Benjamin Saxon |
Medical Unit Head, Haematology and Oncology; WCHN |
Prof Bryone Kuss |
Head of Haematology Services, Molecular Medicine and Genetics; FMC/ SA Pathology |
Ms Cheri Ostroff |
Consumer representative |
Prof Chris Karapetis |
Director, Cancer Services, Consultant Medical Oncologist; SALHN |
Prof David Roder |
Research Chair, Cancer Epidemiology and Population Health, Senior Principal Research Fellow; South Australian Health and Medical Research Institute (SAHMRI)/ University of South Australia |
Dr Elizabeth Murphy |
Divisional Director (Medical) Division of Surgical Specialties and Anaesthetics, Colorectal Surgeon; NALHN |
Ms Gabrielle Vigar |
Nurse Unit Manager, Radiation Oncology/Cancer Outpatients, CALHN |
Ms Hayley Vasileff |
Lead Cancer Services Pharmacist; SA Pharmacy/Rural Support Service |
Mrs Helen Phillips |
Advanced Nurse Consultant, Cancer Services Team; Rural Support Service |
Mrs Joanne Glover |
Deputy Chair Clinical Network, Cancer Clinical Program Delivery Manager, Affiliate Senior Lecturer Adelaide Medical School; CALHN/ University of Adelaide |
Ms Kim Morey |
Co-Theme Leader, Aboriginal Health Equity Strategy Health Systems Research; SAHMRI |
Dr Luke Johnson |
Sarcoma & Bone Tumour, Limb Salvage & Arthroplasty Surgeon, Head of SA Bone & Soft Tissue Tumour Unit; FMC/ WCH/ RAH |
Mr Mark Haseloff |
Consumer representative |
Mr Michael Fitzgerald |
Nurse Practitioner- Medical Oncology FMC Cancer Services; SALHN |
Dr Michelle Damin |
Haematologist; NALHN |
Dr Nadia Corsini |
Senior Research Fellow; University of South Australia |
Ms Rebekah Lamb |
Nursing Director, Division of Medicine; NALHN |
Prof Timothy Price |
Medical Oncologist TQEH and Medical Lead Cancer Program; CALHN |
Network Lead
Dr Michael Osborn
Cancer Statewide Clinical Network Vision
The Cancer Clinical Network’s vision is for excellence and innovation in cancer care for South Australians.
Cancer Statewide Clinical Network Goals
The Cancer Statewide Clinical Network aims to bring together health professionals and consumers to provide strategic guidance and advice relating to cancer care and work on projects to improve health outcomes for all South Australians affected by cancer.
The Cancer Statewide Clinical Network aims to improve health outcomes for all South Australians affected by cancer. We do this by:
- being person-centred.
- focusing on compassionate and equitable care.
- working in collaborative partnerships with key stakeholders across the entire cancer continuum.
- building on latest evidence to drive excellence and innovation.
- driving improvements in safety, quality and patient experience.
- providing strategic expertise and advice on cancer care.
Achievements of the Cancer Statewide Clinical Network
- Systemic therapy standards – state-wide vs national mapping
- Development of data strategy for cancer outcomes
- Completion of a‘standard systemic cancer treatment’ consent form
- Commenced Chemotherapy National Standards Supporting document
- Development of COVID-19 cancer vaccination documents – for consumers and health professionals
Additional Documents and Information
- List of Support Services for Cancer (373 KB, PDF)
- South Australian Supplementary Standard for Systemic Cancer Therapy (852 KB, PDF)
- National Safety and Quality Health Service Standards- User Guide for Medication Management in Cancer Care (2 MB, PDF)
- Consent to Systemic Cancer Treatment Form (201 KB, PDF)
Terms of Reference
Have a question?
Or want to know more about the Cancer Statewide Clinical Network?
Please email CEIHCancer@sa.gov.au